ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Health Gorilla and Amwell Announce Expanded Digital Diagnostic Lab Ordering for Clinicians

With a more connected and efficient digital lab process, Health Gorilla and Amwell reinforce their commitment to accessible hybrid care

Health Gorilla, a privacy-focused health information network and interoperability solution provider, and Amwell® (NYSE: AMWL), a global leader in hybrid care enablement, announce a new lab capability within the Amwell Converge™ virtual care platform. Providers practicing on the Converge platform will be able to offer patients a more connected hybrid care experience through streamlined lab processes, enhanced digital diagnostic data capabilities, and access to a broader nationwide lab network.

An individual’s medical journey is highly dependent on diagnostic lab results. Up to 70% of clinical decisions are influenced by laboratory results1 and approximately 30% of patient encounters result in a provider ordering a lab test2. Secure digital access to diagnostic results is essential for a seamless patient experience. This new lab capability is a natural extension of Amwell’s commitment to enabling accessible virtual care by granting providers practicing on the Converge platform expanded access to lab orders and results from patients’ preferred lab networks, including local, regional and nationwide lab companies.

"Health Gorilla’s lab automation system is leveraged by leading provider organizations to automate their clinical workflows, and we’re thrilled to add Amwell as our newest collaborator," said Steve Yaskin, chief executive officer at Health Gorilla. "Labs are a critical variable in the patient's care journey, and we're proud to empower providers using the Amwell Converge platform with more access to diagnostic data."

The Converge platform enables providers, insurers, patients and innovators to deliver more affordable, higher quality care across all hybrid environments, including in-person, virtual and automated care. As part of the expanded partnership, Health Gorilla’s lab automation system will optimize diagnostic ordering, which will increase the efficiency of Amwell clinicians, leading to faster diagnoses and improved patient outcomes. With access to Health Gorilla’s APIs within the Converge platform, providers can place lab orders electronically, review test results and automate manual processes all from one platform.

“As more primary and specialty care providers make the move to virtual, we see how data and analytics can inform and influence patient care – at the point of care – in ways they haven’t been able to with in-person visits,” said Roy Schoenberg, president and chief executive officer at Amwell. “With Health Gorilla’s new superpowers integrated in our platform, providers can go beyond lab data and access broader insights that enable them to adapt patient care in real-time. This makes Health Gorilla the right strategic partner for Amwell and our collective goals.”

Health Gorilla and Amwell will be present at HLTH 2023 conference, Oct. 8-10 in Las Vegas. In a session titled, “CEO Perspectives on the Future of Hybrid Care” both company leaders will discuss the future of virtual care, emergence of hybrid care models and state of the overall healthcare market. The session begins at 10:30 a.m. PT on Monday, Oct. 9 at booth 3029.

About Amwell:

Amwell provides a leading hybrid care enablement platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. The company offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the hybrid care of more than 55 health plans, which collectively represent more than 90 million covered lives, and many of the nation’s largest health systems, representing over 2,000 hospitals, have access to Amwell solutions. For more information, please visit https://business.amwell.com/.

American Well, Amwell, Converge, Conversa, SilverCloud and Carepoints are registered trademarks or trademarks of American Well Corporation in the United States and other countries. All other trademarks used herein are the property of their respective owners.

About Health Gorilla:

Health Gorilla is a secure health data sharing platform, powering national health information exchange while protecting patient data privacy and security. Health Gorilla provides access to the broadest network of real-time healthcare data sources in the U.S., making it easy for authorized users to get a complete view of their patients. Through our collaborations with healthcare providers, insurers, and government organizations, we play a vital role in improving health outcomes, reducing administrative inefficiencies, and unlocking new business models. Health Gorilla is also one of the applicants accepted for onboarding as a candidate Qualified Health Information Network and must successfully complete testing and onboarding before official designation as a QHIN. Our platform hosts innovative privacy technologies designed to safeguard health data and protect patient privacy. For more information, visit healthgorilla.com or follow us on LinkedIn and on Twitter @HealthGorilla.

1tps://www.cdc.gov/csels/dls/strengthening-clinical-labs.html

2tps://implementationscience.biomedcentral.com/articles/10.1186/s13012-015-0356-4

 

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.